Professor Jason Carroll

November 11, 2021

Jason’s lab is interested in defining the role of transcription factors in cancer, with a specific focus on hormone-dependent cancers (Estrogen Receptor positive breast cancer and prostate cancer). They develop genomic and proteomic tools to be able to define the genes and proteins that are important in cancer progression. A major focus of the lab is understanding the role of specialised transcription factors called pioneer factors, in initiating gene regulatory events in cancer.

Professor Jason Carroll
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect